沃华医药涨2.13%，成交额2233.58万元，主力资金净流入132.69万元

Core Insights - Wohuah Pharmaceutical's stock price increased by 2.13% on October 31, reaching 6.22 CNY per share, with a total market capitalization of 3.59 billion CNY [1] - The company has seen a year-to-date stock price increase of 33.48%, but has experienced a slight decline of 0.32% over the last five trading days [1] Financial Performance - For the period from January to September 2025, Wohuah Pharmaceutical reported a revenue of 625 million CNY, representing a year-on-year growth of 8.31% [2] - The net profit attributable to shareholders for the same period was 63.995 million CNY, showing a significant year-on-year increase of 179.34% [2] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 41,000, up by 17.18% from the previous period [2] - The average number of circulating shares per shareholder decreased by 14.66% to 13,892 shares [2] Dividend Distribution - Since its A-share listing, Wohuah Pharmaceutical has distributed a total of 692 million CNY in dividends, with 214 million CNY distributed over the last three years [3] Institutional Holdings - As of September 30, 2025, notable new institutional shareholders include Baodao Jiuhang Mixed A and Guotai Haitong CSI 500 Index Enhanced A, holding 998,900 shares and 931,200 shares respectively [3]